Evidence map›Paper›PMID 25162004›Full record

ReviewBioMed research international2014

Autophagy in HCV infection: keeping fat and inflammation at bay.

Tiziana Vescovo, Giulia Refolo, Alessandra Romagnoli, Fabiola Ciccosanti, Marco Corazzari, Tonino Alonzi, Gian Maria Fimia

Abstract readReview
In one paragraph

Review in BioMed research international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Autophagy in HCV Replication and Protein Trafficking.International journal of molecular sciences · 2021
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Hepatitis C virus and the kidney.Nature reviews. Nephrology · 2019
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tiziana VescovoNational Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, IRCCS, 00149 Rome, Italy.ORCID 0000-0002-4987-5014
Giulia RefoloNational Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, IRCCS, 00149 Rome, Italy.ORCID 0000-0002-5519-7395
Alessandra RomagnoliNational Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, IRCCS, 00149 Rome, Italy.
Fabiola CiccosantiNational Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, IRCCS, 00149 Rome, Italy.ORCID 0000-0003-0481-6878
Marco CorazzariNational Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, IRCCS, 00149 Rome, Italy ; Department of Biology, "Tor Vergata" University of Rome, 00173 Rome, Italy.ORCID 0000-0002-6246-5968
Tonino AlonziNational Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, IRCCS, 00149 Rome, Italy.
Gian Maria FimiaNational Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, IRCCS, 00149 Rome, Italy ; Department of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Salento, 73100 Lecce, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis C virus (HCV) infection is one of the main causes of chronic liver disease. Viral persistence and pathogenesis rely mainly on the ability of HCV to deregulate specific host processes, including lipid metabolism and innate immunity. Recently, autophagy has emerged as a cellular pathway, playing a role in several aspects of HCV infection. This review summarizes current knowledge on the molecular mechanisms that link the HCV life cycle with autophagy machinery. In particular, we discuss the role of HCV/autophagy interaction in dysregulating inflammation and lipid homeostasis and its potential for translational applications in the treatment of HCV-infected patients.

Indexed as

AutophagyHepacivirusHepatitis CHost-Pathogen InteractionsHumansImmunity, InnateInflammationSignal TransductionVirus Replication

Identifiers

PMID25162004
PMCPMC4138948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.